Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Topical Raplixa for Surgical Bleeding in Children

ClinicalTrials.gov ID: NCT02117349

Public ClinicalTrials.gov record NCT02117349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Single-Blind, Controlled Trial of Topical Raplixa™ (Fibrin Sealant [Human]) in Intraoperative Surgical Hemostasis in a Pediatric Population

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine if Raplixa plus Gelfoam is better than Gelfoam alone in stopping mild to moderate bleeding in children having surgery.

Study identification

NCT ID
NCT02117349
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mallinckrodt
Industry
Enrollment
55 participants

Conditions and interventions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2014 (Actual)
Primary completion
Nov 17, 2017 (Actual)
Completion
Mar 6, 2018 (Actual)
Last update posted
Feb 5, 2020

2014 – 2018

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Arizona Burn Center at Maricopa Medical Center Phoenix Arizona 85008 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Shriners Hospital for Children Sacramento California 95817 —
Nemours Children's Specialty Care Jacksonville Florida 32207 —
Children's Healthcare of Atlanta Atlanta Georgia 30322 —
Ann and Robert H Lurie Childrens Hospital of Chicago Chicago Illinois 60611 —
Saint Louis Children's Hospital St Louis Missouri 63110 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157 —
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134 —
SGM Physician Research Consortium, LLC Wayne Pennsylvania 19087 —
Children's Medical Center Dallas Dallas Texas 90027 —
Carilion Clinic Roanoke Virginia 24013 —
Seattle Children's Hospital - PIN Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02117349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2020 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02117349 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →